Morasco Benjamin J, O'Hearn Daniel, Turk Dennis C, Dobscha Steven K
Mental Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, Oregon, USA; Center to Improve Veteran Involvement in Care, Portland VA Medical Center, Portland, Oregon, USA; Department of Psychiatry, Oregon Health & Science University, Portland, Oregon, USA.
Pain Med. 2014 Nov;15(11):1902-10. doi: 10.1111/pme.12472. Epub 2014 Jun 14.
Chronic pain is associated with impairments in sleep; however, the relationship between prescription opioid status and sleep is unclear. The primary aim of this study was to examine differences in self-reported sleep quality between groups of patients who varied based on chronic pain and prescription opioid status.
This is a cross-sectional study with retrospective review of patient medical records.
The study was performed in a single VA medical center located in the Pacific Northwest.
Participants with chronic pain and a current prescription for opioid medications (N=72), chronic pain and no opioid prescription (N=104), or who did not report current chronic pain or opioid prescription (N=91) were included.
All participants completed self-report questionnaires assessing demographic characteristics, sleep parameters, pain-related variables, and psychiatric symptoms. Data on prescription opioid use were extracted from patients' medical records.
In unadjusted analyses, patients with chronic pain who were prescribed opioids were more likely to have sleep apnea diagnoses in their medical record and reported more impairment on sleep global score and across four sleep parameter subscales (subjective sleep quality, sleep latency, sleep disturbance, and use of sleeping medications). In linear regression analyses controlling for demographic and clinical covariates, prescription opioid status was associated with sleep latency, and opioid dose was significantly associated with sleep latency and sleep global score.
Prescription opioid status and dose were associated with impairment in self-reported sleep. For patients with chronic pain, consideration should be given to use of nonpharmacological interventions to improve sleep.
慢性疼痛与睡眠障碍相关;然而,处方阿片类药物状态与睡眠之间的关系尚不清楚。本研究的主要目的是探讨根据慢性疼痛和处方阿片类药物状态分组的患者在自我报告睡眠质量方面的差异。
这是一项对患者病历进行回顾性审查的横断面研究。
该研究在位于太平洋西北部的一家退伍军人事务部医疗中心进行。
纳入了患有慢性疼痛且目前正在使用阿片类药物处方的参与者(N = 72)、患有慢性疼痛但无阿片类药物处方的参与者(N = 104),或未报告当前慢性疼痛或阿片类药物处方的参与者(N = 91)。
所有参与者均完成自我报告问卷,评估人口统计学特征、睡眠参数、疼痛相关变量和精神症状。从患者病历中提取处方阿片类药物使用的数据。
在未调整的分析中,开具阿片类药物处方的慢性疼痛患者在病历中更有可能被诊断为睡眠呼吸暂停,并且在睡眠总体评分以及四个睡眠参数子量表(主观睡眠质量、睡眠潜伏期、睡眠障碍和使用睡眠药物)上报告的损害更大。在控制了人口统计学和临床协变量的线性回归分析中,处方阿片类药物状态与睡眠潜伏期相关,阿片类药物剂量与睡眠潜伏期和睡眠总体评分显著相关。
处方阿片类药物状态和剂量与自我报告的睡眠损害相关。对于慢性疼痛患者,应考虑使用非药物干预措施来改善睡眠。